Pulse nav.journalClub Débats actifs Tendances Explorer Chercheurs

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Accueil Explorer nav.journalClub Tendances

⌘+K

© Synapse Social LLC, 2026

Politique de confidentialité

June 1, 2005Open Access

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults

Key Points

Key points are not available for this paper at this time.

Abstract

The zoster vaccine markedly reduced morbidity from herpes zoster and postherpetic neuralgia among older adults.

Read Full Paperexternally

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Demander à l'IA

Like

Bookmark

Share

View Full Paper

A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults | Synapse

Cite This Study

Oxman et al. (Wed,) studied this question.

synapsesocial.com/papers/69d9a35aa1d151c65f684b30 https://doi.org/https://doi.org/10.1056/nejmoa051016

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine2003 · 320 citations
2Selective decline in cellular immune response to varicella‐zoster in the elderly

1980 · 286 citations

3Clinical manifestations of herpes zoster2000 · 53 citations

4Reduction in burden of illness: A new efficacy measure for prevention trials1994 · 51 citations

5The sequelae of herpes zoster1997 · 14 citations